Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,825 signal articles · 254 in last 24h · 118,324 total before filter · latest 39m ago
254last 24h
1559last 7d
252● bullish (7d)
161● bearish (7d)
205publishers
AllMacro300Earnings630M&A97Regulatory28Product14Analyst23
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Salesforce faces a vital Agentforce test in upcoming earnings
TheStreet84d agoneutral
Salesforce faces a vital Agentforce test in upcoming earnings

Few companies in enterprise software have staked their future as explicitly on a single product bet as Salesforce has on Agentforce. The agentic AI platform has been the centerpiece of every investor conversation, every earnings call, and every product announcement for the past two quarters. ...

Trading at 7x Earnings in an AI Boom? This Is the ‘Stupid Cheap’ Stock Your Financial Advisor Won’t Tell You About
24/7 Wall St.84d agoneutral
Trading at 7x Earnings in an AI Boom? This Is the ‘Stupid Cheap’ Stock Your Financial Advisor Won’t Tell You About

Consider Micron Technology (NASDAQ:MU) here because a forward FY 2027 earnings multiple of 7x on a company sitting at the literal center of the AI memory bottleneck is a valuation that almost never exists at the heart of a megatrend, and the only reason it does now is that your advisor still thinks “memory” means ... Trading at 7x Earnings in an AI Boom? This Is the ‘Stupid Cheap’ Stock Your Financial Advisor Won’t Tell You About

BofA makes blunt call on HOKA-parent Deckers stock price after earnings
TheStreet84d agoneutral
BofA makes blunt call on HOKA-parent Deckers stock price after earnings

Deckers Outdoor (DECK) walked into its earnings night with everything a footwear company could want. Record fiscal 2026 revenue, record EPS, a blockbuster $3.5 billion buyback authorization, and a fiscal 2027 outlook that came in above Wall Street's consensus. Then, Bank of America trimmed its ...

Assessing Johnson & Johnson (JNJ) Valuation After Guidance Raise Growth Initiatives And Talc Litigation Update
Simply Wall St.84d agoneutral
Assessing Johnson & Johnson (JNJ) Valuation After Guidance Raise Growth Initiatives And Talc Litigation Update

Johnson & Johnson (JNJ) is in focus after a Minnesota jury included the company in a US$10.2 million mesothelioma verdict tied to asbestos contaminated cosmetic talc products, adding to its broader talc related legal exposure. See our latest analysis for Johnson & Johnson. Despite headlines around talc litigation, Johnson & Johnson’s stock has had a 13.02% year to date share price return. Its 1 year total shareholder return of 55.84% points to strong momentum built over a longer stretch, even...